CHEMBIOBRIDGE RESEARCH AND SERVICES PRIVATE LIMITED

ChemBioBridge is committed to driving scientific excellence and interdisciplinary collaboration to forge a sustainable future. Our research and innovation efforts are designed to create real-world impact and improve quality of life globally by addressing some of the most pressing challenges in health and the environment. At ChemBioBridge, our interdisciplinary team of highly skilled researchers and innovators led by Dr. Dolly Sharma and Dr. Amaresh Mishra work tirelessly to create benchmark products and technologies across three key domains: Biotechnology, Healthcare, and Environmental R&D. Each area focuses on utilizing advancements in science and technology to drive sustainable innovation and create impactful solutions. The domains Drug Discovery (Nanoformulation Based): Our drug discovery and development team is focussed on developing novel nanoformulation-based drugs to enhance efficacy and target specificity, revolutionizing treatment paradigms. This research and innovation is driven by a novel objective of integrating ancient Indian Ayurvedic wisdom with cutting edge nano-biotechnology to develop robust and target specific clinically impactful ‘NanoVedic’ formulations from Indian and Asian botanicals of reported medicinal values. Multidrug Resistance: The MDR team primarily investigates novel mechanisms to develop alternatives to antibiotics in order to address the global challenge of increasing multidrug resistance in pathogenic bacteria. Our research strives to develop innovative safe and viable biotherapeutic intervention to combat the alarming global crisis of multidrug-resistant
bacterial infections.